NCT07494890 Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment
| NCT ID | NCT07494890 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Cincinnati |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 18 participants |
| Start Date | 2026-06-25 |
| Primary Completion | 2027-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 18 participants in total. It began in 2026-06-25 with a primary completion date of 2027-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Walking impairment following neurologic injury can increase the energy cost of walking threefold, acting as a functional barrier to independence. The goal of this cross-sectional study is to determine the measurement properties of a novel biomechanical cost of walking measure in chronic stroke capable of pinpointing the origins of movement inefficiencies. This research aims to: 1. determine the convergent validity of biomechanical cost of walking with functional measures in relation to metabolic cost of walking, 2. determine the reliability of biomechanical cost of walking in relation to metabolic cost of walking, 3. determine the responsiveness of biomechanical cost of walking in relation to metabolic cost of walking. Individuals with walking impairment from stroke will complete three 5-minute comfortable speed treadmill walking trials. The 3rd walking trial will be against resistance to increase cost of walking. This single session study will compare the metric properties of biomechanical cost of walking in relation to metabolic cost of walking.
Eligibility Criteria
Inclusion Criteria: * Age 30-80 years at the time of consent * Hemiparesis from ischemic and/or hemorrhagic strokes * Most recent stroke for which participant sought treatment, at least 3 months prior to study consent * Walking speed \<1.0 m/s on the 10-meter walk test * Able to walk 10m over ground with assistive devices as needed * Able to walk at least 5 minutes continuously on the treadmill ≥ 0.1 mile per hour * No contraindications to exercise according to ACSM guidelines * Able to communicate with investigators, follow a 2-step command and correctly answer consent comprehension questions Exclusion Criteria: * Hospitalization for cardiac or pulmonary disease within past 3 months * Implanted pacemaker or defibrillator * Severe lower limb hypertonia (Ashworth \>2) * Foot drop or lower limb joint instability without adequate stabilizing device * Clinically significant neurologic disorder other than stroke * Other significant medical condition likely to jeopardize safety (e.g. joint contracture, gait limited by pain) * Pregnancy
Contact & Investigator
Christina Garrity, DPT
PRINCIPAL INVESTIGATOR
University of Cincinnati
Frequently Asked Questions
Who can join the NCT07494890 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, up to 80 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07494890 currently recruiting?
Yes, NCT07494890 is actively recruiting participants. Contact the research team at garritca@mail.uc.edu for enrollment information.
Where is the NCT07494890 trial being conducted?
This trial is being conducted at Cincinnati, United States.
Who is sponsoring the NCT07494890 clinical trial?
NCT07494890 is sponsored by University of Cincinnati. The principal investigator is Christina Garrity, DPT at University of Cincinnati. The trial plans to enroll 18 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.